Introduction
Libtayo, also known as cemiplimab-rwlc, is a prescription medication used for the treatment of certain types of cancer. It belongs to a class of drugs known as immune checkpoint inhibitors, which work by helping the body's immune system fight cancer cells. One important aspect of using Libtayo effectively is understanding the recommended dosage and how to administer the medication.
Recommended Dosage
The recommended dosage of Libtayo can vary depending on the type of cancer being treated and the patient's weight and overall health. It is typically administered as an intravenous infusion every few weeks. Your healthcare provider will determine the specific dosage and schedule that is right for you.
Administration Instructions
Libtayo should only be administered by healthcare professionals who are experienced in giving intravenous medications. The medication is usually given in a hospital or clinic setting. Follow your healthcare provider's instructions carefully, and do not attempt to self-administer Libtayo.
Potential Side Effects
Like all medications, Libtayo can cause side effects. Common side effects may include fatigue, nausea, diarrhea, and skin reactions. More serious side effects are possible but rare. Contact your healthcare provider if you experience any unusual symptoms while taking Libtayo.
Precautions
Before starting treatment with Libtayo, inform your healthcare provider about any medical conditions you have and any other medications you are taking. Certain medications or health conditions may interact with Libtayo or increase the risk of side effects. Pregnant women should not use Libtayo, as it may harm the unborn baby.